These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3814214)

  • 61. Effects of nifedipine on cardiac function in patients with coronary artery disease evaluated with ambulatory radionuclide monitoring.
    Kambara H; Mohiuddin IH; Tamaki N; Fudo T; Hayashi M; Nohara R; Konishi J; Kawai C
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():919-22. PubMed ID: 2076400
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of nisoldipine in silent myocardial ischemia after healing of acute myocardial infarction.
    Nohara R; Hata T; Hosokawa R; Lee L; Fujita M; Kambara H; Sasayama S
    Am J Cardiol; 1995 Apr; 75(13):54E-60E. PubMed ID: 7726126
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of nisoldipine on exercise performance in heart failure following myocardial infarction.
    Lewis BS; Makhoul N; Merdler A; Flugelman MY; Front A; Hardoff R; Halon DA
    Cardiology; 1991; 79(1):39-45. PubMed ID: 1777913
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prostacyclin effect on cardiovascular system in man evaluated by echocardiography.
    Triulzi MO; Cirino D; Gentile F; Balice G; Aguggini G; Maggi GC
    Prostaglandins Med; 1981 Dec; 7(6):501-10. PubMed ID: 7034023
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Intracoronary nisoldipine: effects on acute myocardial ischemia during coronary angioplasty.
    Amende I; Herrmann G; Simon R; Wenzlaff P; Lichtlen PR
    Cardiovasc Drugs Ther; 1989 Jan; 2(6):807-13. PubMed ID: 2488096
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevention of pacing-induced silent myocardial ischaemia by nifedipine in coronary heart disease.
    Pust B; Sebenik M; Obrez I
    Eur Heart J; 1988 Dec; 9 Suppl N():151-7. PubMed ID: 3246248
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man.
    van Harten J; van Brummelen P; Zeegers RR; Danhof M; Breimer DD
    Br J Clin Pharmacol; 1988 Jun; 25(6):709-17. PubMed ID: 3203043
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Effect of molsidomine preparations on the contractile function of the myocardium and coronary circulation in patients with ischemic heart disease complicated by heart failure after isometric load].
    Alekperov EZ
    Kardiologiia; 1989 Apr; 29(4):44-7. PubMed ID: 2754913
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Single- and multiple-dose nisoldipine kinetics and effects in the young, the middle-aged, and the elderly.
    van Harten J; Burggraaf J; Ligthart GJ; van Brummelen P; Breimer DD
    Clin Pharmacol Ther; 1989 Jun; 45(6):600-7. PubMed ID: 2731403
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Nisoldipine--a new orally administered calcium antagonist used in the treatment of severe postpartum pregnancy-induced hypertension. Preliminary results.
    Belfort MA; Kirshon B
    S Afr Med J; 1992 Mar; 81(5):267-70. PubMed ID: 1542820
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vasodilatory effects of nisoldipine on coronary arteries--correlation with plasma levels.
    Jost S; Rafflenbeul W; Mogwitz B; Gulba D; Hecker H; Lichtlen PR
    Cardiovasc Drugs Ther; 1990 Feb; 4(1):273-9. PubMed ID: 2285621
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The contribution of nisoldipine-induced changes in liver blood flow to its pharmacokinetics after oral administration.
    van Harten J; Burggraaf J; Danhof M; van Brummelen P; Breimer DD
    Br J Clin Pharmacol; 1989 May; 27(5):581-6. PubMed ID: 2757881
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The accuracy of functional parameters extracted from ventricular time-activity curves by Fourier curve fitting: a simulation study.
    Ormerod OJ; Barber RW; Wraight EP
    Nucl Med Commun; 1986 Feb; 7(2):91-103. PubMed ID: 3714155
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dynamic stress echocardiography for evaluating anti-ischemic drug profiles in post-MI patients.
    Nixdorff U; Erbel R; Wagner S; Buck T; Mertes H; Mohr-Kahaly S; Meyer J
    Int J Card Imaging; 1997 Dec; 13(6):485-91. PubMed ID: 9415850
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The pharmacology of nisoldipine.
    Knorr A
    Cardiovasc Drugs Ther; 1987 Dec; 1(4):393-402. PubMed ID: 3154674
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
    Friedel HA; Sorkin EM
    Drugs; 1988 Dec; 36(6):682-731. PubMed ID: 3065058
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of oral nisoldipine in ischemic heart disease. A radioisotopic study.
    Tartagni F; Rùggiero S; Melandri G; Beato E; Dondi M; Monetti N; Magnani B
    Arzneimittelforschung; 1986 Oct; 36(10):1528-31. PubMed ID: 3814214
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Comparison of the acute hemodynamic effect of nisoldipine (Bay k 5552) and nifedipine in patients with ischemia-induced left ventricular impaired function].
    Aschenberg W; Nienaber C; Spielmann R; Bleifeld W
    Z Kardiol; 1988 Apr; 77(4):238-44. PubMed ID: 3291444
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Antianginal effect of calcium antagonists, using nisoldipine as an example].
    Hess OM; Krayenbühl HP
    Schweiz Med Wochenschr; 1984 Aug; 114(33):1126-31. PubMed ID: 6484542
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effects of nisoldipine on left ventricular function during exercise or cold pressor stress.
    Dymond DS; Caplin JL; O'Keefe JC; Banim S
    Eur Heart J; 1987 Nov; 8 Suppl K():27-33. PubMed ID: 3450520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.